Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
237
-
Total shares
-
3.58M
-
Shares change
-
-426K
-
Total reported value, excl. options
-
$550M
-
Value change
-
-$66.2M
-
Number of buys
-
74
-
Number of sells
-
-122
-
Price
-
$153.77
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q1 2024
232 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q1 2024.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 237 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.58M shares
.
Largest 10 shareholders include MORGAN STANLEY (467K shares), WELLS FARGO & COMPANY/MN (430K shares), LPL Financial LLC (251K shares), UBS Group AG (233K shares), Royal Bank of Canada (173K shares), Berger Financial Group, Inc (148K shares), Raymond James Financial Services Advisors, Inc. (119K shares), RAYMOND JAMES & ASSOCIATES (111K shares), OSAIC HOLDINGS, INC. (62.4K shares), and COMMONWEALTH EQUITY SERVICES, LLC (57.6K shares).
This table shows the top 237 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.